Skip to main content
. 2017 Feb;38(2):112–117. [Article in Chinese] doi: 10.3760/cma.j.issn.0253-2727.2017.02.006

图7. 慢性髓性白血病接受酪氨酸激酶抑制剂治疗患者进展期出现与未出现额外染色体异常(ACA)组总生存比较.

图7